ASHBURN, Va., Dec. 4, 2025 /PRNewswire/ -- DXC Technology (NYSE: DXC), a leading enterprise technology and innovation partner, and Aptys Solutions, a provider of end-to-end payments solutions serving more than 5,500 U.S. financial institutions, today announced a strategic partnership to accelerate payments modernization and simplify how financial institutions (FIs) connect to and manage payments services across networks and channels. The partnership will enable FIs to enhance efficiency, reduce operational risk, and improve customer and member experiences.
Aptys Solutions delivers a unified payments platform that supports ACH, wire, instant payments (FedNow® and RTP®), image exchange, and digital channels, along with directory services, fraud controls, and funds management tools. Through this partnership, DXC will integrate Aptys' payments connectivity and orchestration capabilities with its banking transformation portfolio, enabling FIs to streamline payments processing, improve interoperability across systems, and reduce total cost of ownership.
Together, DXC and Aptys aim to democratize access to next-generation banking innovation. While Aptys' network of more than 5,500 community banks and credit unions represents a critical part of the U.S. financial ecosystem, these institutions often lack the same access to cutting-edge capabilities as the largest banks. Through this partnership, FIs of all sizes will now be able to tap into DXC's modernization and innovation stack—including embedded finance, digital assets, and AI-driven services—delivered seamlessly through Aptys' payments platform.
"FIs are seeking practical ways to modernize payments while managing cost, complexity, and risk," said Sandeep Bhanote, Global Head and General Manager of Financial Services at DXC. "By combining Aptys' modern payments infrastructure with DXC's deep expertise in core banking environments, we are helping financial institutions take a phased, pragmatic approach to modernization."
Aptys provides API-based connectivity for account verification, balance inquiry, directory services, payments initiation, and messaging. Today, many FIs support these services at cost while third parties access and resell the resulting data at significant margins. Together, DXC and Aptys will enable direct bank-to-bank processing and help institutions capture more of the value generated by their own payments infrastructure, reducing reliance on intermediary fintech layers and strengthening control and transparency across payments workflows.
"Aptys Solutions empowers thousands of financial institutions to deliver payment experiences that are faster, smarter, and more secure," said Naseer Nasim, Chief Executive Officer of Aptys Solutions. "Our partnership with DXC brings the scale, reliability, and operational strength required to help institutions modernize with confidence while keeping trust at the center of every payment relationship."
The initial phase of the partnership focuses on enabling core payments API transactions, with plans to build upon these foundational use cases to modernize traditional financial infrastructure and enhance the way institutions deliver services. Future phases will introduce new capabilities such as digital wallets, custody, and wealth management services.
About DXC Technology
DXC (NYSE: DXC) is a leading enterprise technology and innovation partner delivering software, services, and solutions to global enterprises and public sector organizations — helping them harness AI to drive outcomes at a time of exponential change with speed. With deep expertise in Managed Infrastructure Services, Application Modernization, and Industry-Specific Software Solutions, DXC modernizes, secures, and operates some of the world's most complex technology estates. Learn more on dxc.com.
About Aptys Solutions
Aptys Solutions is a premier provider of end-to-end payments technology. Our unified platform powers ACH, wires, international wires, checks, and real-time payments through FedNow® and RTP®. More than 5,500 financial institutions trust Aptys to process billions of dollars in transactions each year. Driven by innovation and a client-centric mission, Aptys enables institutions to modernize their payment ecosystems, reduce complexity, unlock new revenue opportunities, and deliver more secure, efficient payment experiences. For more information, visit aptyssolutions.com.
Media Contacts: DXC, Ashley Houk-Temple, Media Relations, +1 520-245-3973, ashley.houktemple@dxc.com; Aptys, pr@aptyssolutions.com
** The press release content is from PR Newswire. Bastille Post is not involved in its creation. **
DXC and Aptys Solutions Partner to Modernize Payments Connectivity for U.S. Financial Institutions
SHANGHAI, April 2, 2026 /PRNewswire/ -- Free tickets for 2026 Medtec open on April 1, 2026. Visitors who complete registration before August 31 can enter free of charge. As Asia's Leading Medical Device Supply Chain Expo — From R&D to Commercial Manufacturing, 2026 Medtec will be held from September 1–3, 2026, at the Shanghai New International Expo Centre (SNIEC), Pudong, Halls N1–N4. On-site registration during the exhibition will incur a 100 RMB admission fee per person.
https://visitorreg.medteccn.com/medtec-en/?utm_medium=pressrelease&utm_source=prnewswire&utm_campaign=register_open&utm_content=en Visit the official website now to claim your free ticket and stay ahead in the industry!
Free Tickets Now Open (April 1 – August 31, 2026)
Free tickets are open through August 31, 2026, offering visitors a more efficient way to plan their visit to 2026 Medtec.
Early Registration Benefits:
- Free access (save up to 100 RMB per person)
- Support for international group registration
- Fast-track entry with no on-site queue
- Flexible visit scheduling
2026 Medtec Overview
Marking its 20th edition, Medtec continues to serve as a comprehensive platform across the full medical device R&D and manufacturing chain, with an exhibition area of 47,000 square meters, 1,100 exhibitors, and an estimated 93,000 visits.
The exhibition provides integrated solutions across R&D, prototyping, manufacturing, certification, mass production, OEM services, and CRO and CDMO capabilities. Exhibits span a wide range of categories, including materials, core components, electronic parts, optical components, surface processing, precision machining, automation equipment, packaging, sterilization, testing, and consulting services.
The exhibition will be organized across four halls at SNIEC, spanning N1-N4.The four halls are structured around key segments of the medical device supply chain, from materials and core components to manufacturing services and equipment.
Halls N1–N2 focus on Medical Materials & Core Components.
Hall N1 Highlights:
- Metal Materials and Their Components
- Orthopedic and Dental Implant Processing Zone
- Ceramics, Biomaterials, Glass, and Other Materials and Related Components
- Ultra-precision Laser Processing, Machine Tools and Additive Manufacturing
Hall N2 Highlights:
- Medical Rubber and Plastic Materials and Their Components
- Bonding Agents, Bonding Products
- IVD Reagents, Filtration, Intravenous Injection, and Laboratories
- Pipe Fittings and Extrusion
- Pharmaceutical Delivery Systems, Dressing Materials and Formulation Processing
Halls N3–N4 focus on Medical Manufacturing Service & Equipment.
Hall N3 Highlights:
- Plastic Film Molding Services and Equipment
- OEM/ODM Contract Manufacturing Services
- Medical Automation, Drive Control, Robotics, Smart Factory
- Pipe Fittings and Extrusion Equipment
- Surface Treatment
Hall N4 Highlights:
- Medical Packaging, Sterilization, Labeling, Cleanroom
- R&D and Design, Software Services, and Consulting Services
- Exhibition of Testing, Metrology, Inspection and Calibration Equipment and Supplies
- Integrated Service Area
Visitor Composition
Medtec's core visitor base includes medical device manufacturers, supply chain companies, and import-export enterprises. Attending representatives span senior executives, directors, engineers, managers, supervisors, and specialists. Their responsibilities cover management, R&D and technical centers, process and manufacturing engineering, quality, supply chain and procurement, as well as regulatory affairs.
It also attracts professionals from hospitals, clinics, and public health institutions, including hospital administrators, department directors and deputy directors, attending physicians, and other healthcare personnel. In addition, researchers and professors from research institutes and universities in medical device-related fields are expected to attend, alongside investors and analysts from the healthcare sector.
2026 Medtec will continue to attract participation from the industry's top buyer companies.
Conclusion
As a key platform for leading companies to launch new products and showcase cutting-edge technologies, Medtec brings together a full spectrum of materials, components, manufacturing equipment, and supporting services. It supports one-stop sourcing while helping global companies connect with the China market.
Free tickets for 2026 Medtec open on April 1 and close on August 31, 2026 — register in advance to secure free admission.
Media Contact
Website: https://en.medtecchina.com/
Talia Li, talia.li@informa.com
Booth Enquiry: LINC, +86 21 6157 7217, linc.cai@informa.com
Visitor and Media Enquiry: Tracy, +86 10 6562 3307, tracy.zhang@informa.com
** This press release is distributed by PR Newswire through automated distribution system, for which the client assumes full responsibility. **
Free Tickets Open for 2026 Medtec
